The world’s most diverse portfolio of injectable technologies
At Galderma, we are proud pioneers. We have the world’s most diverse portfolio of injectable technologies. This means that we can meet individual patient aspirations and supply healthcare practitioners with the right tools to provide a holistic treatment approach. Our ambition is to continue to develop innovative aesthetic solutions that live up to or exceed patients’ expectations.
We constantly strive for a higher standard. We have a strong heritage built on over two decades of aesthetic innovation, with experience from over 85 million treatments worldwide.1 As a company rooted in science, we have the most referenced clinical studies and hundreds of scientific papers published, contributing to an unmatched patient safety record. All our products are manufactured in Europe.
Over 85 million treatments worldwide2
Most diverse portfolio of injectable technologies
20+ years of aesthetic innovation
Pioneering aesthetic treatments
From the start, innovation has been at the heart of everything we do. At Galderma, we help patients realize their own individual beauty goals by continuously developing new technologies and techniques that are clinically proven and effective. We deliver decades of research and development, the most referenced clinical studies and hundreds of scientific papers published contributing to a strong patient safety record with over 85 million treatments worldwide.3
REFERENCES
1 Data on file (MA-39680).; Data on file (MA-40221).; Data on file (MA-39613).
2 Data on file (MA-39680).; Data on file (MA-40221).; Data on file (MA-39613).
3 Data on file (MA-39680).; Data on file (MA-40221).; Data on file (MA-39613).